Company
Takeda Pharmaceutical Company Limited
740 Legal Matters
46
514
180

Takeda Pharmaceutical Company Limited Company IP News and Updates

Pedram Sameni
Patexia Insight 153: Top ANDA Firms of 2022
Pedram Sameni
Sep 29, 2022
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused...
Read More
Pedram Sameni
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni
Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the...
Read More
Pedram Sameni
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
Pedram Sameni
Sep 15, 2022
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by...
Read More
Knobbe Martens
Preliminary Injunction Denied Because of Failure to Draft Precise Terms That Capture the Intent of the Parties
Knobbe Martens
Aug 4, 2020
TAKEDA PHARMACEUTICALS U.S.A., INC. V. MYLAN PHARMACEUTICALS INC. Before Prost, Newman, and Hughes. Appeal from the United States District Court...
Read More
Knobbe Martens
Despite Change in Motion to Amend Practice by Aqua Products, PTAB Orders Scope of Remand to be Limited to Federal Circuit’s Decision
Knobbe Martens
Apr 12, 2018
In an IPR on remand from the Federal Circuit on appeal of a motion to amend, the PTAB considered the...
Read More
Showing 1-5 of 5 news found